| Patent | Date |
|---|
GABAA receptor ligand
Grant 11,396,510 - Larsen , et al. July 26, 2 | 2022-07-26 |
Selective Agonist Of Alpha6 Containing nAChRs
App 20220143014 - Dyhring; Tino ; et al. | 2022-05-12 |
Potassium Channel Modulators
App 20210380571 - Amrutkar; Dipak Vasantrao ; et al. | 2021-12-09 |
A GABAA Receptor Ligand
App 20210332042 - LARSEN; Janus S. ; et al. | 2021-10-28 |
Potassium channel modulators
Grant 10,717,728 - Amrutkar , et al. | 2020-07-21 |
Potassium Channel Modulators
App 20190352293 - Amrutkar; Dipak Vasantrao ; et al. | 2019-11-21 |
Potassium channel modulators
Grant 10,351,553 - Amrutkar , et al. July 16, 2 | 2019-07-16 |
Selective Agonist Of a6 Containing nAChRs
App 20180311238 - Dyhring; Tino ; et al. | 2018-11-01 |
Potassium Channel Modulators
App 20180215746 - Amrutkar; Dipak Vasantrao ; et al. | 2018-08-02 |
Methods For The Treatment Of Tremors By Positive Modulation Of Sk Channels
App 20180207138 - Amrutkar; Dipak Vasantrao ; et al. | 2018-07-26 |
Potassium channel modulators
Grant 9,975,886 - Amrutkar , et al. May 22, 2 | 2018-05-22 |
Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
Grant 9,133,184 - Peters , et al. September 15, 2 | 2015-09-15 |
Chromen-2-one Derivatives And Their Use As Monoamine Neurotransmitter Re-uptake Inhibitors
App 20140235669 - PETERS; Dan ; et al. | 2014-08-21 |
Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
Grant 8,697,721 - Peters , et al. April 15, 2 | 2014-04-15 |
Chromen-2-one Derivatives And Their Use As Monoamine Neurotransmitter Re-uptake Inhibitors
App 20130040985 - Peters; Dan ; et al. | 2013-02-14 |
Chromen-2-one Derivatives And Their Use As Monoamine Neurotransmitter Re-uptake Inhibitors
App 20120088789 - Peters; Dan ; et al. | 2012-04-12 |
2-(phenylamino) benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
Grant 7,960,561 - Sorensen , et al. June 14, 2 | 2011-06-14 |
Novel Quinolinylamide Derivatives Useful As Modulators Of Dopamine And Serotonin Receptors
App 20110085978 - Peters; Dan ; et al. | 2011-04-14 |
Novel Aryl Piperazine Derivatives Useful As Modulators Of Dopamine And Serotonin Receptors
App 20110059019 - Peters; Dan ; et al. | 2011-03-10 |
Novel 2-amino Benzimidazole Derivatives And Their Use As Modulators Of Small-conductance Calcium-activated Potassium Channels
App 20110034527 - SORENSEN; Ulrik Svane ; et al. | 2011-02-10 |
2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
Grant 7,842,817 - Sorensen , et al. November 30, 2 | 2010-11-30 |
Novel 2-amino Benzimidazole Derivatives And Their Use As Modulators Of Small-conductance Calcium-activated Potassium Channels
App 20100280087 - Sorensen; Ulrik Svane ; et al. | 2010-11-04 |
2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
Grant 7,737,167 - Sorensen , et al. June 15, 2 | 2010-06-15 |
Aryl Piperazine Derivatives Useful For The Treatment Of Neuropsychiatry Disorders
App 20100087445 - Campiani; Giuseppe ; et al. | 2010-04-08 |
Novel Aryl Piperazine Derivatives With Medical Utility
App 20090238761 - Campiani; Giuseppe ; et al. | 2009-09-24 |
2-(Phenylamino) Benzimidazole Derivatives and Their Use as Modulators of Small- Conductance Calcuim-Activated Potassium Channels
App 20090076106 - Sorensen; Ulrik Svane ; et al. | 2009-03-19 |
Novel 2-Amino Benzimidazole Derivatives and Their Use As Modulators Of Small-Conductance Calcium-Activated Potassium Channels
App 20080200529 - Sorensen; Ulrik Svane ; et al. | 2008-08-21 |
Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
App 20070197618 - Sorensen; Ulrik Svane ; et al. | 2007-08-23 |
Benzothiazine derivatives, their preparation and use
Grant 7,199,118 - Gouliaev , et al. April 3, 2 | 2007-04-03 |
Adenosine A.sub.2A receptor antangonists combined with neurotrophic activity compounds in the treatment of Parkinson's disease
Grant 7,160,899 - Peters , et al. January 9, 2 | 2007-01-09 |
Adenosine a2a receptor antangonists combined with neurotrophic activity compounds in the treatment of parkinson's disease
App 20040097540 - Peters, Dan ; et al. | 2004-05-20 |
| 